Thalidomide prolongs PFS following androgen failure: Commentary
Publication
, Journal Article
Armstrong, AJ
Published in: Oncology Report
September 1, 2008
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2008
Issue
FALL
Start / End Page
40
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J. (2008). Thalidomide prolongs PFS following androgen failure: Commentary. Oncology Report, (FALL), 40.
Armstrong, A. J. “Thalidomide prolongs PFS following androgen failure: Commentary.” Oncology Report, no. FALL (September 1, 2008): 40.
Armstrong AJ. Thalidomide prolongs PFS following androgen failure: Commentary. Oncology Report. 2008 Sep 1;(FALL):40.
Armstrong, A. J. “Thalidomide prolongs PFS following androgen failure: Commentary.” Oncology Report, no. FALL, Sept. 2008, p. 40.
Armstrong AJ. Thalidomide prolongs PFS following androgen failure: Commentary. Oncology Report. 2008 Sep 1;(FALL):40.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2008
Issue
FALL
Start / End Page
40
Related Subject Headings
- Oncology & Carcinogenesis